Literature DB >> 2931356

Effect of cyclosporine and aminophylline on streptozotocin-induced diabetes in rats.

E Ferrero, A Marni, M E Ferrero, G Gaja, C Rugarli.   

Abstract

Diabetes induced in rats by multiple low doses of streptozotocin is thought to mimic type 1 disease in man. We tested the effect of concomitant treatment with immunomodulator drugs in this diabetic experimental model. Administration of cyclosporine resulted in a rapid appearance of hyperglycemia, perhaps by a potentiation of the direct cytotoxic action of streptozotocin on beta cells. By contrast, aminophylline administration protected the animals from the diabetogenic action of streptozotocin. Concomitant treatment with aminophylline and cyclosporine failed to protect the rats from the hyperglycemia induced by streptozotocin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2931356     DOI: 10.1016/0165-2478(85)90075-6

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

1.  Theophylline protects against diabetes in BB rats and potentiates cyclosporine protection.

Authors:  A Rabinovitch; W L Sumoski
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

2.  Immunomodulation of low dose streptozocin diabetes in mice reveals that insulitis is not obligatory for B cell destruction.

Authors:  G Papaccio; G Chieffi Baccari; V Esposito
Journal:  J Anat       Date:  1992-12       Impact factor: 2.610

3.  The immunosuppressant FK506 inhibits the damage to mouse pancreatic islets induced by low dose streptozocin.

Authors:  G Papaccio; M Latronico; G Chieffi Baccari
Journal:  Cell Tissue Res       Date:  1994-09       Impact factor: 5.249

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.